Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Feb;7(1):11-8.
doi: 10.1161/CIRCINTERVENTIONS.113.000679. Epub 2014 Feb 4.

Angiographic validation of the American College of Cardiology Foundation-the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies study

Affiliations
Comparative Study

Angiographic validation of the American College of Cardiology Foundation-the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies study

Anjan K Chakrabarti et al. Circ Cardiovasc Interv. 2014 Feb.

Abstract

Background: The goal of this study was to compare angiographic interpretation of coronary arteriograms by sites in community practice versus those made by a centralized angiographic core laboratory.

Methods and results: The study population consisted of 2013 American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) records with 2- and 3- vessel coronary disease from 54 sites in 2004 to 2007. The primary analysis compared Registry (NCDR)-defined 2- and 3-vessel disease versus those from an angiographic core laboratory analysis. Vessel-level kappa coefficients suggested moderate agreement between NCDR and core laboratory analysis, ranging from kappa=0.39 (95% confidence intervals, 0.32-0.45) for the left anterior descending artery to kappa=0.59 (95% confidence intervals, 0.55-0.64) for the right coronary artery. Overall, 6.3% (n=127 out of 2013) of those patients identified with multivessel disease at NCDR sites had had 0- or 1-vessel disease by core laboratory reading. There was no directional bias with regard to overcall, that is, 12.3% of cases read as 3-vessel disease by the sites were read as <3-vessel disease by the core laboratory, and 13.9% of core laboratory 3-vessel cases were read as <3-vessel by the sites. For a subset of patients with left main coronary disease, registry overcall was not linked to increased rates of mortality or myocardial infarction.

Conclusions: There was only modest agreement between angiographic readings in clinical practice and those from an independent core laboratory. Further study will be needed because the implications for patient management are uncertain.

Keywords: angiography; catheterization; percutaneous coronary intervention; program evaluation.

PubMed Disclaimer

Conflict of interest statement

Disclosures

The primary author reports no conflicts. Dr Peterson has received consulting fees and honoraria from Janssen Pharmaceuticals, Inc, Genentech, Boehringer Ingelheim as well as research grants from Eli Lilly and Janssen Pharmaceuticals, Inc. Dr Weintraub has received consulting fees and honoraria from Eli Lilly, Bristol Myers Squibb, Pfizer, and Amarin. Dr Gibson has received consulting fees and honoraria from Johnson & Johnson Corp, Bayer Corporation, Ischemix, Inc, BCRI, Sanofi-Aventis Corp, Genentech, Inc, Merck & Co, CSL Behring, Biogen Idec, Daiichi Sankyo, Inc, Bristol Meyer Squibb, The Medicines Company, Janssen Pharmaceuticals, Inc, Regado Biosciences, Inc, St. Jude Medical Corp., Ortho McNeil, Portola Pharmaceuticals, Eli Lilly, and GlaxoSmithKline, as well as research grants from Lantheus Medical Imaging, Janssen Pharmaceuticals, Inc, Bayer Corporation, Genentech Inc, Merck & Co, Atrium Medical Systems, Roche Diagnostics, Ikaria, Inc, Portola Pharmaceuticals, Johnson & Johnson Corp, Angel Medical Corporation, Volcano Corp, Stealth Peptides, Sanofi-Aventis, Walk Vascular, and St Jude’s Medical, as well as other financial support from UpToDate in Cardiovascular Medicine. All other authors report no conflicts.

Figures

Figure 1
Figure 1
Study population. Records available from Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) study with angiographic analysis performed at the Percutaneous/Pharmacologic Endoluminal Revascularization for Unstable Syndrome and its Evaluation (PERFUSE) angiographic core laboratory.
Figure 2
Figure 2
Analysis of clinical outcomes by left main agreement. Survival curves were estimated using the Kaplan–Meier (KM) method for censored data. Follow-up time was administratively censored on December 31, 2008. For myocardial infarction (MI), patients who died were retained in the denominator, that is, these patients were not censored on date of death. The resulting KM curves are interpreted as actual rather than actuarial probabilities. The log-rank test evaluates whether there is difference between the survival curves. A, KM curve for the outcome of death. B, Curve for recurrent MI.

Similar articles

Cited by

References

    1. Chan PS, Patel MR, Klein LW, Krone RJ, Dehmer GJ, Kennedy K, Nallamothu BK, Weaver WD, Masoudi FA, Rumsfeld JS, Brindis RG, Spertus JA. Appropriateness of percutaneous coronary intervention. JAMA. 2011;306:53–61. - PMC - PubMed
    1. Costa RA, Reiber JH. QCA editorial. Int J Cardiovasc Imaging. 2011;27:155–156. - PubMed
    1. Brener SJ, Haq SA, Bose S, Sacchi TJ. Three-year survival after percutaneous coronary intervention according to appropriateness criteria for revascularization. J Invasive Cardiol. 2009;21:554–557. - PubMed
    1. Stone GW, Moses JW. Interventional cardiology: how should the appropriateness of PCI be judged? Nat Rev Cardiol. 2011;8:544–546. - PubMed
    1. Bradley SM, Chan PS, Spertus JA, Kennedy KF, Douglas PS, Patel MR, Anderson HV, Ting HH, Rumsfeld JS, Nallamothu BK. Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDR. Circ Cardiovasc Qual Outcomes. 2012;5:290–297. - PMC - PubMed

Publication types

MeSH terms